AFYREN, the innovative Greentech for sustainable chemistry, launches its IPO on Euronext Growth® in Paris
- A capital increase of approximately €70 million, which may be increased to above €80 million if the extension clause is exercised
- Indicative offering price range: €8.02 to €9.72 per share
- Subscription commitments of €32.66 million to €35.00 million from Bpifrance, Mirova, Sofinnova Biotech Partner 1 and Crédit Agricole Centre France Developpement
- French public offering closes on: 27 September 2021 (at 5.00pm over-the-counter and 8.00pm online)
- Global placement closes on: 28 September 2021 (at 12.00pm)
- Securities eligible for French SME equity savings plans (PEA-PME)
Clermont-Ferrand/Lyon, 14 September 2021 – AFYREN, a greentech company that offers manufacturers natural and low-carbon products produced using a technology based on natural micro-organisms, announces the launch of its IPO with a view to listing its shares on the Paris Euronext Growth® market (ISIN code: FR-0014005AC9 mnemonic: ALAFY).
On 13 September 2021, the French financial markets authority (AMF) approved, under number 21-397, the prospectus for the IPO of AFYREN, comprising the registration document, approved under number I. 21-042 and dated 25 August 2021, a securities note and a summary of the Prospectus (included in the securities note).
Last news
AFYREN receives €4 million in grants for AFYREN NEOXY and starts new performance-driven investment strategy
Press release
AFYREN begins new phase of industrial strategy as first plant AFYREN NEOXY achieves continuous production
Press release Availability of preparatory documents for the Combined General Meeting on June 17, 2025
Press release
AFYREN achieves “Responsible Care® Confirmed Diagnosis” certification and publishes its second sustainability report
Press release
AFYREN and Südzucker celebrate 5 years of strategic bioeconomy partnership
Press release AFYREN strengthens its Executive Committee with appointment of Laurent Pou as Industrial Director
Press release